Comments
Loading...

Viking Therapeutics Analyst Ratings

VKTXNASDAQ
Logo brought to you by Benzinga Data
$28.95
0.602.12%
At close: -
$28.90
-0.05-0.17%
After Hours: 7:55 PM EDT
Consensus Rating1
Buy
Highest Price Target1
$138.00
Lowest Price Target1
$12.00
Consensus Price Target1
$77.58

Viking Therapeutics Analyst Ratings and Price Targets | NASDAQ:VKTX | Benzinga

Viking Therapeutics Inc has a consensus price target of $77.58 based on the ratings of 19 analysts. The high is $138 issued by Oppenheimer on September 25, 2024. The low is $12 issued by SVB Leerink on April 28, 2022. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Scotiabank, and Citigroup on March 11, 2025, February 13, 2025, and February 7, 2025, respectively. With an average price target of $80.67 between HC Wainwright & Co., Scotiabank, and Citigroup, there's an implied 179.12% upside for Viking Therapeutics Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
4
Nov 24
3
Dec 24
3
Jan
5
1
Feb
1
Mar
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.9
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Scotiabank
Citigroup
Maxim Group
B. Riley Securities

1calculated from analyst ratings

Analyst Ratings for Viking Therapeutics

Buy NowGet Alert
03/11/2025Buy Now252.94%HC Wainwright & Co.
Joseph Pantginis46%
$102 → $102ReiteratesBuy → BuyGet Alert
02/13/2025Buy Now252.94%Scotiabank
George Farmer50%
→ $102Initiates → Sector OutperformGet Alert
02/07/2025Buy Now31.49%Citigroup
David Lebowitz51%
→ $38Initiates → NeutralGet Alert
02/07/2025Buy Now142.21%Maxim Group
Naz Rahman28%
$120 → $70MaintainsBuyGet Alert
02/07/2025Buy Now232.18%B. Riley Securities
Mayank Mamtani72%
$109 → $96ReiteratesBuy → BuyGet Alert
02/06/2025Buy Now332.53%Raymond James
Steven Seedhouse59%
$122 → $125MaintainsStrong BuyGet Alert
02/06/2025Buy Now145.67%Piper Sandler
Biren Amin40%
$74 → $71MaintainsOverweightGet Alert
02/06/2025Buy Now252.94%HC Wainwright & Co.
Joseph Pantginis46%
$102 → $102ReiteratesBuy → BuyGet Alert
01/17/2025Buy Now252.94%HC Wainwright & Co.
Joseph Pantginis46%
$102 → $102ReiteratesBuy → BuyGet Alert
01/10/2025Buy Now252.94%HC Wainwright & Co.
Joseph Pantginis46%
$102 → $102ReiteratesBuy → BuyGet Alert
01/08/2025Buy Now252.94%HC Wainwright & Co.
Joseph Pantginis46%
$102 → $102MaintainsBuyGet Alert
12/20/2024Buy Now252.94%HC Wainwright & Co.
Joseph Pantginis46%
$102 → $102ReiteratesBuy → BuyGet Alert
12/18/2024Buy Now252.94%HC Wainwright & Co.
Joseph Pantginis46%
$102 → $102ReiteratesBuy → BuyGet Alert
12/02/2024Buy Now156.06%Piper Sandler
Biren Amin40%
→ $74Initiates → OverweightGet Alert
11/27/2024Buy Now252.94%HC Wainwright & Co.
Joseph Pantginis46%
$102 → $102ReiteratesBuy → BuyGet Alert
11/26/2024Buy Now252.94%HC Wainwright & Co.
Joseph Pantginis46%
$102 → $102ReiteratesBuy → BuyGet Alert
11/22/2024Buy Now277.16%B. Riley Securities
Mayank Mamtani72%
→ $109Initiates → BuyGet Alert
11/05/2024Buy Now252.94%HC Wainwright & Co.
Joseph Pantginis46%
$90 → $102MaintainsBuyGet Alert
10/24/2024Buy Now211.42%HC Wainwright & Co.
Joseph Pantginis46%
$90 → $90ReiteratesBuy → BuyGet Alert
10/09/2024Buy Now211.42%HC Wainwright & Co.
Joseph Pantginis46%
$90 → $90ReiteratesBuy → BuyGet Alert
09/25/2024Buy Now377.51%Oppenheimer
Jay Olson62%
$138 → $138ReiteratesOutperform → OutperformGet Alert
09/12/2024Buy Now263.32%Morgan Stanley
Michael Ulz58%
$105 → $105ReiteratesOverweight → OverweightGet Alert
09/11/2024Buy Now176.82%JP Morgan
Hardik Parikh10%
→ $80Initiates → OverweightGet Alert
07/25/2024Buy Now308.3%Raymond James
Steven Seedhouse59%
$116 → $118MaintainsStrong BuyGet Alert
07/25/2024Buy Now211.42%HC Wainwright & Co.
Joseph Pantginis46%
$90 → $90ReiteratesBuy → BuyGet Alert
06/27/2024Buy Now263.32%Morgan Stanley
Michael Ulz58%
→ $105Initiates → OverweightGet Alert
06/24/2024Buy Now211.42%HC Wainwright & Co.
Joseph Pantginis46%
$90 → $90ReiteratesBuy → BuyGet Alert
06/17/2024Buy Now315.22%Truist Securities
Joon Lee78%
$120 → $120MaintainsBuyGet Alert
06/04/2024Buy Now—Raymond James
Steven Seedhouse59%
—Reiterates → Strong BuyGet Alert
06/04/2024Buy Now315.22%Maxim Group
Naz Rahman28%
$120 → $120ReiteratesBuy → BuyGet Alert
06/04/2024Buy Now211.42%HC Wainwright & Co.
Joseph Pantginis46%
$90 → $90ReiteratesBuy → BuyGet Alert
05/16/2024Buy Now315.22%Truist Securities
Joon Lee78%
$120 → $120ReiteratesBuy → BuyGet Alert
05/16/2024Buy Now301.38%Raymond James
Steven Seedhouse59%
$115 → $116UpgradeOutperform → Strong BuyGet Alert
04/25/2024Buy Now211.42%HC Wainwright & Co.
Joseph Pantginis46%
$90 → $90ReiteratesBuy → BuyGet Alert
03/27/2024Buy Now377.51%Oppenheimer
Jay Olson62%
$116 → $138MaintainsOutperformGet Alert
03/26/2024Buy Now211.42%HC Wainwright & Co.
Joseph Pantginis46%
$90 → $90ReiteratesBuy → BuyGet Alert
03/26/2024Buy Now377.51%Oppenheimer
Jay Olson62%
$116 → $138MaintainsOutperformGet Alert
03/26/2024Buy Now332.53%BTIG
Justin Zelin41%
$100 → $125MaintainsBuyGet Alert
03/15/2024Buy Now211.42%HC Wainwright & Co.
Joseph Pantginis46%
$90 → $90ReiteratesBuy → BuyGet Alert
03/15/2024Buy Now315.22%Maxim Group
Naz Rahman28%
$120 → $120ReiteratesBuy → BuyGet Alert
03/15/2024Buy Now176.82%Stifel
Annabel Samimy68%
→ $80ReiteratesBuy → BuyGet Alert
03/15/2024Buy Now246.02%BTIG
Justin Zelin41%
$86 → $100MaintainsBuyGet Alert
03/08/2024Buy Now211.42%HC Wainwright & Co.
Joseph Pantginis46%
$90 → $90ReiteratesBuy → BuyGet Alert
03/07/2024Buy Now280.62%Jefferies
Roger Song33%
→ $110Initiates → BuyGet Alert
02/29/2024Buy Now315.22%Truist Securities
Joon Lee78%
$32 → $120MaintainsBuyGet Alert
02/28/2024Buy Now301.38%Oppenheimer
Jay Olson62%
$46 → $116MaintainsOutperformGet Alert
02/27/2024Buy Now297.92%Raymond James
Steven Seedhouse59%
$37 → $115MaintainsOutperformGet Alert
02/27/2024Buy Now211.42%HC Wainwright & Co.
Joseph Pantginis46%
$33 → $90MaintainsBuyGet Alert
02/14/2024Buy Now21.11%Stifel
Annabel Samimy68%
$30 → $35MaintainsBuyGet Alert
02/08/2024Buy Now73.01%Maxim Group
Naz Rahman28%
$35 → $50MaintainsBuyGet Alert
12/04/2023Buy Now10.73%Truist Securities
Joon Lee78%
→ $32ReiteratesBuy → BuyGet Alert
10/02/2023Buy Now10.73%Truist Securities
Joon Lee78%
→ $32ReiteratesBuy → BuyGet Alert
08/08/2023Buy Now3.81%Stifel
Annabel Samimy68%
→ $30Reiterates → BuyGet Alert
07/27/2023Buy Now14.19%HC Wainwright & Co.
Joseph Pantginis46%
→ $33ReiteratesBuy → BuyGet Alert
06/27/2023Buy Now10.73%Truist Securities
Joon Lee78%
→ $32ReiteratesBuy → BuyGet Alert
05/31/2023Buy Now10.73%Roth MKM
Dylan Dupuis61%
→ $32Assumes → BuyGet Alert
05/17/2023Buy Now28.03%Raymond James
Steven Seedhouse59%
$35 → $37MaintainsOutperformGet Alert
05/16/2023Buy Now38.41%Oppenheimer
Jay Olson62%
$35 → $40MaintainsOutperformGet Alert
05/16/2023Buy Now3.81%Stifel
Annabel Samimy68%
$25 → $30MaintainsBuyGet Alert
05/16/2023Buy Now24.57%BTIG
Justin Zelin41%
$31 → $36MaintainsBuyGet Alert
05/08/2023Buy Now14.19%HC Wainwright & Co.
Joseph Pantginis46%
→ $33Reiterates → BuyGet Alert
05/03/2023Buy Now-16.96%Roth MKM
Scott Henry47%
$19 → $24MaintainsBuyGet Alert
04/27/2023Buy Now21.11%Oppenheimer
Jay Olson62%
→ $35Reiterates → OutperformGet Alert
04/27/2023Buy Now14.19%HC Wainwright & Co.
Joseph Pantginis46%
$21 → $33MaintainsBuyGet Alert
04/25/2023Buy Now21.11%Oppenheimer
Jay Olson62%
$30 → $35MaintainsOutperformGet Alert
03/29/2023Buy Now-34.26%Roth MKM
Matt Koranda54%
$15 → $19MaintainsBuyGet Alert
03/29/2023Buy Now-13.49%Maxim Group
Anthony Vendetti57%
$15 → $25MaintainsBuyGet Alert
03/29/2023Buy Now10.73%Truist Securities
Joon Lee78%
$28 → $32MaintainsBuyGet Alert
03/29/2023Buy Now21.11%Raymond James
Steven Seedhouse59%
$12 → $35MaintainsOutperformGet Alert
03/29/2023Buy Now7.27%BTIG
Justin Zelin41%
$20 → $31MaintainsBuyGet Alert
03/28/2023Buy Now3.81%Oppenheimer
Jay Olson62%
$20 → $30MaintainsOutperformGet Alert
03/28/2023Buy Now-13.49%Stifel
Annabel Samimy68%
$22 → $25MaintainsBuyGet Alert
03/17/2023Buy Now-23.88%Stifel
Annabel Samimy68%
→ $22Initiates → BuyGet Alert
02/09/2023Buy Now-58.48%Raymond James
Steven Seedhouse59%
$11 → $12MaintainsOutperformGet Alert
02/09/2023Buy Now-27.34%HC Wainwright & Co.
Joseph Pantginis46%
→ $21Reiterates → BuyGet Alert
12/20/2022Buy Now-48.1%Maxim Group
Naz Rahman28%
$10 → $15MaintainsBuyGet Alert
10/27/2022Buy Now-61.94%Raymond James
Steven Seedhouse59%
$10 → $11MaintainsOutperformGet Alert
04/28/2022Buy Now-58.48%SVB Leerink
Thomas Smith33%
$18 → $12MaintainsOutperformGet Alert

FAQ

Q

What is the target price for Viking Therapeutics (VKTX) stock?

A

The latest price target for Viking Therapeutics (NASDAQ:VKTX) was reported by HC Wainwright & Co. on March 11, 2025. The analyst firm set a price target for $102.00 expecting VKTX to rise to within 12 months (a possible 252.94% upside). 38 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Viking Therapeutics (VKTX)?

A

The latest analyst rating for Viking Therapeutics (NASDAQ:VKTX) was provided by HC Wainwright & Co., and Viking Therapeutics reiterated their buy rating.

Q

When was the last upgrade for Viking Therapeutics (VKTX)?

A

The last upgrade for Viking Therapeutics Inc happened on May 16, 2024 when Raymond James raised their price target to $116. Raymond James previously had an outperform for Viking Therapeutics Inc.

Q

When was the last downgrade for Viking Therapeutics (VKTX)?

A

There is no last downgrade for Viking Therapeutics.

Q

When is the next analyst rating going to be posted or updated for Viking Therapeutics (VKTX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Viking Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Viking Therapeutics was filed on March 11, 2025 so you should expect the next rating to be made available sometime around March 11, 2026.

Q

Is the Analyst Rating Viking Therapeutics (VKTX) correct?

A

While ratings are subjective and will change, the latest Viking Therapeutics (VKTX) rating was a reiterated with a price target of $102.00 to $102.00. The current price Viking Therapeutics (VKTX) is trading at is $28.90, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch